Augustina Isioma Ikusemoro: Thalassaemia is Not Just Anaemia – It’s a Genetic Story That Shapes
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“Thalassaemia: It’s not just anaemia – it’s a genetic story that shapes outcomes.
Behind every microcytic blood film lies a deeper question:
Is this iron deficiency… or something inherited?
Thalassaemia is a disorder of globin chain synthesis, where the body cannot produce normal amounts of alpha or beta globin chains, leading to ineffective red cell production and varying degrees of anaemia.
Here’s what truly matters clinically:
The genetics define the disease
- Alpha-globin genes are located on chromosome 16
- Beta-globin genes are located on chromosome 11
Most α-thalassaemia cases are caused by gene deletions.
This is a key distinction – especially when interpreting microcytosis with normal iron studies.
Severity depends on how many gene copies are affected:
- Loss of 1–2 genes leads to mild or asymptomatic
- Loss of 3 genes leads to moderate to severe disease
- Loss of all 4 genes leads to Hydrops fetalis (Hb Bart’s) — often fatal without intervention
This is why thalassaemia should never be approached as ‘just another anaemia.’
It requires:
- Understanding of genetic patterns
- Correlation with RBC indices and Hb analysis
- Awareness of population risk and inheritance patterns
Because accurate diagnosis is not just academic – it directly impacts:
- Patient management
- Genetic counselling
- Prenatal outcomes
The real takeaway?
- Don’t just treat anaemia.
- Understand the biology behind it.
When you understand the genes, you diagnose with precision.
— Signature of Blood Doki
Educate.
Empower.
Elevate.”

Find more posts featuring Augustina Isioma Ikusemoro on Hemostasis Today.
-
Jun 26, 2026, 13:58Peter Bou Dib: How Factor IX Transformed Hemophilia B Treatment
-
Jun 26, 2026, 13:49Raghavendra Rao: The Surprising Link Between Chronic Venous Insufficiency and Falls
-
Jun 26, 2026, 13:40Caylynn Carls: Why Genetic Counseling Matters in Hemophilia Treatment
-
Jun 26, 2026, 13:25Ángel Cabrera: Clotting Disorders Behind Heavy Menstrual Bleeding
-
Jun 26, 2026, 13:02Turid Kjellevold: The Critical Role of Timely Hemostasis Testing
-
Jun 26, 2026, 10:59Wolfgang Miesbach: How Clonal Hematopoiesis May Explain Age-Related Mitochondrial Mutations
-
Jun 26, 2026, 10:52Chinua Onyebuchi: The Future of Stroke Care in Africa Lies in Strong Health Systems
-
Jun 26, 2026, 10:35Habtamu Milkias Wolde: New Insights into Stroke and Traumatic Brain Injury from Global Burden of Disease Data
-
Jun 26, 2026, 10:19Rytis Masiliūnas: Atrial Fibrillation and Stroke Care Disparities Across the Baltic Region